Feyi Ayodele: These New Features Take Our Mission Further Than Ever Before
Feyi Ayodele, Founder and CEO at Cancer IQ, shared CancerIQ’s post on LinkedIn:
“So proud to reunite with Heather Landi after all these years and see Fierce Healthcare feature this next step for CancerIQ. What we’ve designed in this product is way better than what people have been getting over the last few years – which is just a score embedded in a mammography report that’s difficult to understand or difficult to act on. These new features – starting with breast MRI – take our mission further than ever before!”
Quoting CancerIQ’s post:
” ‘Providing patients with a cancer risk score or identifying those at high risk is only one step in cancer prevention. Getting patients to act on their cancer risk and get supplemental screening is the next big leap, and CancerIQ is focused on closing this gap,’ Heather Landi writes in a new feature via Fierce Healthcare.
‘The company, which offers healthcare providers a cancer-focused precision health platform, developed new capabilities to provide patients at elevated risk for cancer with ‘hyper-personalized’ patient education, engagement and navigation support. The new features were built on insights from thousands of high-risk patient journeys and backed by behavioral science with the aim to drive sustained follow-through on supplemental screenings that detect cancer earlier, according to executives.’
More posts featuring Oncology.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023